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A personal tribute to Ralph Kirsch
To the Editor: The last few months have been awkward for a 
few reasons. The first was that Ralph’s illness and subsequent 
passing seemed so sudden. The second was that when one is 
not close family appropriate behaviour is elusive, and finally 
because there are things I felt were left unsaid.
Ralph’s many academic and organisational achievements 
have been eloquently told by many and are not the subject of 
this personal account. Let me explain. When I first met Ralph 
in the mid 1990s, he struck me as a talkative, overly nice, 
trying-to-make-up-for-apartheid type of man. Our family later 
moved to Oxford, and one day Ralph and Beverley happened 
to pass through. Amidst the pleasantries, I was struck by how 
much attention they both gave to our children – then 7 and 5. 
Ralph established that what the children missed most about 
Cape Town was playing in the swimming pool. By the end of 
the visit, the kids had an open invitation to swim in his pool. 
After 2 years of seemingly unending English winters we visited 
Cape Town, arriving on a warm summer’s day. Needless to 
say, we were made to deliver on the promise and spent far too 
many hours in the blazing sun.
A few years after our final return home, I sat for my final 
specialist examinations of the College of Dermatologists. I 
hate to admit that I failed the examination. Many reading this 
will have no idea of what that feels like: it’s like a gnawing 
pain that eats one inside, a pain so deep that it threatens 
to overwhelm. Words of comfort came from many sides, 
including my favourite which I still use to this day: ‘When 
writing an undergraduate exam, you’ve passed unless you 
fail yourself; for specialist exams, you’ve failed until you pass 
yourself.’ It makes sense, as supposedly the buck stops with 
specialists. In the midst of this dark cloud, Ralph phoned 
unexpectedly one evening. He uncharacteristically said only 
a few words, something like, ‘Nonhlanhla, I know this is a 
difficult time, but I just want you to know that I also had to 
repeat my FCP examination’. That was it! I was to turn those 
words round and round in my mind for many months. He was 
a busy Head of Department who did something he did not 
have to do, and that was completely unexpected. And for me it 
was timely and crucial encouragement.
My specialist training left me with a deep desire to explore 
scientifically unanswered questions on the causes of and 
treatments for alopecia. I enrolled to do a PhD in Public Health 
at UCT, having naïvely overestimated the attractiveness of 
hair loss to potential research funders. When I’d exhausted my 
options, I went to Ralph who listened and encouraged me to 
pursue this unlikely research subject in spite of sceptical smiles 
and sometimes open criticism. He advised on various options 
and I was able to do the first 2 years full-time through funding 
from the Carnegie Fund. The rest, as they say, is history! I have 
no doubt that I would have completed the PhD  … eventually, 
but it would have been much harder and taken much longer 
doing it part-time.
What do I now think of Ralph Kirsch? He was a kind man, 
who cared about apparently insignificant things like organising 
a swimming date for sun-starved children. He went beyond 
expectation and encouraged the best in me. He was my hero. 
Hamba kahle qhawe! Akuhlanga lungehlanga, Beverley nabantwana. 
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Sudden death on an aeroplane 
To the Editor: I was much interested in the report by 
Tiemensma et al.1 Considering the extent of the tension 
pneumothorax as seen in Fig. 1, one would have thought 
that the doctors on board should have diagnosed it – was the 
clinical examination done properly? Was the position of the 
trachea palpated, the thoracic cage percussed, auscultation of 
lung and heart sounds done?
With the wonderful and rapid progression of technology and 
sophisticated diagnostic facilities, it seems that the importance 
of a proper and detailed medical history, and the value of a 
complete, meticulous and careful physical examination, are no 
longer appreciated.
My impression is that the subject is neglected in present-day 
teaching of medical students. Too time consuming? Life too 
hurried?
I know of a case in which after a (normal) computed 
tomography brain scan in a stuporous patient, the correct 
diagnosis of diabetes was eventually made. I can cite several 
similar examples.
Patients also constantly complain that their doctors appear 
so busy that there is no time for questions or explanations.
My ‘window of medical experience’ over several decades 
convinces me that there is still a place for a basic down-to-earth 
clinical approach. Many doctors are going to work far from 
tertiary care centres.
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Pathology request guidelines:  
Haematology questioned
To the Editor: We refer to the Haematology section of the 
article by Stanfliet, King and Pillay.1
The assessment of iron deficiency anemia (IDA) 
is incomplete without demonstrating iron-deficient 
erythropoiesis, by looking at the red cell indices (mean 
corpuscular volume, mean cell haemoglobin and mean cell 
haemoglobin concentration (MCV, MCH and MCHC)).2,3 A 
serum ferritin is mandatory if the indices suggest microcytic 
hypochromic anaemia (MHA). A low ferritin confirms IDA, but 
a normal ferritin does not exclude iron deficiency. A normal 
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or raised ferritin may also indicate another cause of MHA, 
such as anaemia of chronic disorder (of which HIV and TB are 
common causes locally).2-4 Therefore, such an over-simplified 
approach will misdiagnose or over-diagnose IDA.
A trial of iron without confirmation of IDA has been 
proposed, but only for patients who are regarded as low-risk. 
Included in this group would be premenopausal women 
and young individuals during growth spurts, especially 
in areas known to have a high prevalence of IDA. Even in 
this group, a trial of therapy with 200 mg of ferrous iron is 
more correctly recommended for 3 weeks prior to review for 
response, as opposed to the 2 months, as suggested by the 
authors.3 A positive response is present when the haemoglobin 
concentration (Hb) has increased by 2 g/dl after 3 weeks 
of therapy. This confirms the diagnosis of IDA, the cause 
of which still needs to be ascertained. Some studies have 
shown a statistically significant prevalence of dual pathology 
in this group of patients.4 In a prospective study of 187 
premenopausal patients with IDA, menorrhagia was present in 
67.4%. A possible gastro-intestinal (GI) cause of IDA was found 
in 57.2% and 43% for the upper and lower GI tract respectively 
(p<0.04 and 0.002). This would easily be missed if therapy is 
given without questioning the need to investigate for a possible 
cause. The main risk factor for the presence of likely GI 
causes in this study was the presence of upper GI symptoms 
(odds ratio 5.2, 95% confidence interval 1.6 -1 6.4, p=0.005).4 
Moreover, in high-risk patients (such as the elderly), a trial of 
iron without establishing a diagnosis of the underlying IDA 
will result in unnecessary delays and is potentially hazardous 
to the patient.
Regarding haemoglobin determinations, there has 
been significant disparity between using the Spencer 
Haemoglobinometer readings and the standard laboratory 
readings reported in the study. Observers’ Hb estimations, 
using the Hbmeter, ranged around 7.2 g/dl and 7.8 g/dl for 
a laboratory Hb of 5.9 g/dl, questioning the accuracy of an 
instrument on which therapeutic decisions may be made.5
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Stanfliet, King and Pillay respond: Linegar et al. investigated 
the Buffalo haemoglobinometer.1 The guidelines recommend 
the use of the Spencer haemoglobinometer from American 
Optical. However, the design and principles of both 
instruments are similar, and identical considerations apply.
The performance of several portable haemoglobinometers is 
not without problems.2 The study cited by Moeng et al. quoting 
a CV of 3% obtained for the Spencer haemoglobinometer, 
was not conducted as would be the case today. No correlation 
co-efficient is stated, and it is not possible to comment on the 
appropriateness of the use of the haemoglobinometer, although 
they recommend it for general practice.3
There is no consensus on the investigation and management 
of iron deficiency anaemia (IDA).2 The gold standard for the 
diagnosis of iron deficiency is bone marrow aspirate stained 
for iron, and no single biomarker can serve as a proxy.2 We 
agree that a blind trial of iron supplementation is inappropriate 
purely on the basis of a portable haemoglobinometer, given 
the poor correlation of some devices in the primary health 
care setting, with some workers reporting a correlation factor 
of 0.61 against a formal haemoglobinometer, but that it serves 
as a screening test for anaemia in a primary health care 
setting.4 Nevertheless, Adamson et al. reported on children 
in the primary health care setting, where they reserved the 
measurement of serum ferritin for those with severe anaemia 
(Hb <9.5 g/dl). Those with milder anaemia purely diagnosed 
by a handheld haemoglobinometer, and no other indices, were 
treated with dietary advice and community follow-up.5
We suggest the use of further markers in addition to the 
hand-held haemoglobinometer to confirm the anaemia 
and to identify its likely cause.2,6 Ferritin and soluble 
transferrin receptors are probably the best biomarkers for the 
assessment of iron status in the absence of inflammation, but 
interpretation in the presence of inflammation and malignancy 
is difficult.2,6-8 Some authors only measure serum ferritin if the 
markers of microcytic anaemia are not consistent with IDA.6 
Spuriously elevated serum ferritin levels can also be seen in 
hepatocellular damage and in situations such as non-steroidal 
anti-inflammatory agent-induced upper gastrointestinal 
bleed.6 Work in the interpretation of ferritin in the setting of 
inflammation and to improve guidelines is urgently needed.7,8
A further consideration is whether a serum ferritin is 
logistically possible or economically feasible in the primary 
health care setting in all patients in our resource-constrained 
settings. Further work is required to expand the current 
evidence base.
Vannella et al. reported that 93.6% of enrolled patients were 
refractory to oral iron supplementation and were referred for 
investigation.9 Their study population had a high incidence of 
coeliac disease and Helicobacter infection, and they suggested 
non-invasive serological tests to better decide who might 
benefit from gastroscopy.9 It therefore appears that referral 
for further investigation and delineation of the cause of IDA 
in ‘low-risk’ patients should be reserved for those who prove 
refractory to a trial of oral iron treatment.
With regard to assessing the response to oral iron therapy, an 
increase in Hb of 2 g/dl in 3 weeks is historically considered as 
